TABLE 3.
Staging for mucosal squamous cell carcinomas (oral cavity, oropharynx, larynx, hypopharynx, sinonasal)
| Total n (%) | COVID period group (%) | Pre‐COVID period group (%) | p‐value | |
|---|---|---|---|---|
| Total number | 121 | 50 | 71 | |
| Tumor (T) classification | ||||
| Tx | 4 (3.3) | 3 (6.0) | 1 (1.4) | 0.025 a |
| T1 | 30 (24.8) | 5 (10.0) | 25 (35.2) | |
| T2 | 33 (27.3) | 16 (32.0) | 17 (23.9) | |
| T3 | 31 (25.6) | 15 (30.0) | 16 (22.5) | |
| T4 | 23 (19.0) | 11 (22.0) | 12 (16.9) | |
| Nodal (N) classification | ||||
| N0 | 50 (41.3) | 22 (44.0) | 28 (39.4) | 0.773 a |
| N1 | 40 (33.1) | 15 (30.0) | 25 (35.2) | |
| N2 | 28 (23.1) | 11 (22.0) | 17 (23.9) | |
| N3 | 3 (2.5) | 2 (4.0) | 1 (1.4) | |
| AJCC 8th edition group stage | ||||
| 1 | 38 (31.4) | 11 (22.0) | 27 (38.0) | 0.170 |
| 2 | 25 (20.7) | 14 (28.0) | 11 (15.5) | |
| 3 | 28 (23.1) | 11 (22.0) | 17 (23.9) | |
| 4 | 30 (24.8) | 14 (28.0) | 16 (22.5) | |
| Median size of primary tumor, longest dimension, cm (range) | 2.8 (0.3–10.0) | 3.0 (1.0–10.0) | 2.5 (0.3–6.4) | 0.092 |
| Median size of largest nodal metastasis, longest dimension, cm (range) | 2.3 (0.8–6.2) | 2.6 (1.0–7.0) | 2.0 (0.8–4.8) | 0.351 |
Note: The italic n indicates number.
a
Fisher's exact test.